Consolidated income statement

CHF million, except share amounts

Note

 

Financial year ended 30.06.2023

%

 

Financial year ended 30.06.2022 (restated) 1

%

Net sales

1.2

 

2,848.8

100.0

 

2,756.9

100.0

Cost of goods sold

 

 

–1,711.6

–60.1

 

–1,675.4

–60.8

Gross margin

 

 

1,137.2

39.9

 

1,081.5

39.2

Sales and marketing

 

 

–484.3

–17.0

 

–449.5

–16.3

General administration

 

 

–283.0

–10.0

 

–265.8

–9.6

Research and development

 

 

–129.6

–4.5

 

–119.0

–4.3

Other operating income

1.4

 

10.8

0.4

 

17.5

0.6

Other operating expenses

1.4

 

–62.1

–2.2

 

–161.7

–5.9

Operating profit (EBIT)

 

 

189.0

6.6

 

103.0

3.7

Result from associates

4.2

 

0.6

0.0

 

0.3

0.0

Financial expenses

1.5

 

–48.9

–1.7

 

–29.5

–1.0

Financial income

1.5

 

1.5

0.1

 

1.1

0.0

Profit before taxes

 

 

142.2

5.0

 

74.9

2.7

Income taxes

1.6

 

–53.7

–1.9

 

–36.1

–1.3

Net profit

 

 

88.5

3.1

 

38.8

1.4

Net profit attributable to minority interests

 

 

42.8

 

 

19.5

 

Net profit attributable to the owners of the parent

 

 

45.7

 

 

19.3

 

Basic earnings per share in CHF

3.3

 

10.9

 

 

4.6

 

Diluted earnings per share in CHF

3.3

 

10.9

 

 

4.6

 

Adjusted EBITDA (Operating profit before depreciation and amortization)

1.1

 

384.8

13.5

 

372.3

13.5

1 dormakaba changed the choice of accounting policies for goodwill accounting as well as the Group internal accounting principles for IT cost allocation. To enable a fair comparison with the current year, the prior-year disclosures have been restated. Details are disclosed in chapter changes in accounting principles and restatement of previous period (5.1).